&format=webp&quality=medium)
Stocks to Watch Today (January 29, 2026): Markets will track the presentation of the Economic Survey, a busy result calendar, key corporate actions, and stock-specific news. Several Nifty and F&O names will remain in focus due to earnings, board decisions, and deal updates.
ITC will be in focus as the company is scheduled to announce its quarterly results. Investors will watch volume trends, margin performance, and commentary on FMCG and cigarette businesses.
Blue Star will be tracked ahead of its quarterly results. Market focus will be on demand outlook in cooling products and margin commentary.
CONCOR is set to announce results post-market. Updates on freight volumes, margins, and logistics demand will be key triggers.
Dabur will report results during market hours. Commentary on rural demand, input costs, and growth in the FMCG portfolio will be closely watched.
KPIT Tech will announce results in the morning session. Investors will track deal wins, growth outlook in auto software, and margin trends.
Paytm is scheduled to declare results during market hours. Focus will be on revenue growth, loss trajectory, and updates on business restructuring.
Prestige Estates will announce results post-market. Sales bookings, cash flows, and project pipeline will be in focus.
REC will be watched as it is set to announce quarterly numbers. Asset quality, loan growth, and disbursement trends will be key.
Swiggy will report results post-market. Investors will track revenue growth, losses, and updates on profitability roadmap.
Canara Bank will be in focus ahead of its results. Market attention will be on asset quality, margins, and credit growth.
Colgate will announce results during market hours. Volume growth and margin performance will remain key triggers.
IEX will declare results post-market. Power volumes, realisations, and regulatory updates will be tracked.
HUDCO is set to report results during market hours. Loan growth and asset quality trends will be watched.
Voltas will remain in focus ahead of its results. Updates on room AC demand and margins will be key.
Dixon Tech will announce results during market hours. Focus will be on order pipeline, new client additions, and margin outlook.
Manappuram Finance will declare results post-market. Asset quality and growth in the gold loan book will be tracked.
Vedanta will be watched ahead of results and amid ongoing focus on group-level corporate actions.
Hindustan Zinc will be in focus as the retail portion of its OFS opens today at a floor price of Rs 685. Vedanta will use the oversubscription option to sell an additional 1.41 crore shares. The non-retail portion has already been subscribed.
Go Fashion will be watched as its board meets to consider a buyback proposal along with quarterly results.
RVNL is in focus after emerging as the L1 bidder through an RVNL-GPT JV for a Northern Railway project worth around Rs 1,201 crore in Uttar Pradesh. The project duration is 48 months.
Max Financial Services is in focus after receiving in-principle approval for its merger with Axis Max Life Insurance. Shareholders will receive shares in Axis Max Life as per the entitlement ratio.
Sai Life Sciences will be tracked after entering a strategic partnership with Mabtech to deliver advanced immunology assay services. The collaboration will strengthen immunology research using the EYRA platform at the Boston site.
L&T reported mixed Q3 results. Revenue and EBITDA were better than estimates, while PAT declined due to a one-time exceptional charge of around Rs 1,191 crore linked to new labour codes. Management remains confident of meeting FY26 growth guidance, supported by a strong order book and robust pipeline.
Phoenix Mills reported mixed Q3 results. Revenue and EBITDA grew year-on-year, but PAT was below estimates. Margins improved sequentially.
Lodha Developers posted Q3 results below estimates. Revenue and PAT rose modestly, while margins declined on a year-on-year basis.
SBI Card reported inline Q3 results with strong PAT growth. Asset quality remained largely stable on a sequential basis.
Piramal Pharma reported weak Q3 results, slipping into a loss. The company cited revenue slowdown due to lower inventory purchases by a large customer, slower US biotech funding recovery, and regulatory delays.
NSDL reported mixed Q3 results. Revenue was marginally lower, while EBITDA and PAT showed year-on-year growth with margin expansion.
Birlasoft posted strong sequential results with growth in revenue and sharp improvement in EBIT margins, despite an exceptional loss in the quarter.
Cochin Shipyard reported mixed Q3 numbers. Revenue rose year-on-year, but EBITDA and PAT declined due to margin pressure.